Kalaris Therapeutics

Developer of therapeutics for retinal disorders

placePalo Alto, California, United States calendar_todayFounded 2024 language kalaristx.com

Social engagement

Social engagement: 5.8K social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record.

Investor typeCountShare
Venture capital233%
Private equity233%
Other / undisclosed233%

Recent activity

17 Mar 2026
Milestone
revenue
5 Mar 2026
Event
Leerink Global Healthcare Conference
8 Sep 2025
Event
Morgan Stanley 23rd Annual Global Healthcare Conference
Coming soon